José is a science news writer with a PhD in Neuroscience from Universidade of Porto, in Portugal. He has also studied Biochemistry at Universidade do Porto and was a postdoctoral associate at Weill Cornell Medicine, in New York, and at The University of Western Ontario in London, Ontario, Canada. His work has ranged from the association of central cardiovascular and pain control to the neurobiological basis of hypertension, and the molecular pathways driving Alzheimer’s disease.
Using veliparib in combination with chemotherapy as first-line and then maintenance therapy post-surgery significantly extended the time without disease progression in women with newly diagnosed metastatic high-grade serous (HGS) ... Read more
A $566,000 grant, awarded via the Ovarian Cancer Research Foundation, will support research in Australia that aims to establish the use of contraceptive pills as an effective strategy for ... Read more
Maintenance treatment with Lynparza (olaparib) is now recommended after response to the first round of platinum-based chemotherapy in women with advanced ovarian cancer on England’s National Health Service (NHS). ... Read more
Maintenance treatment with Zejula (niraparib) extended the time without disease worsening in women with advanced ovarian cancer who had responded to first-line chemotherapy, according to updated results of a ... Read more
Combining the experimental therapy MDNA55 with anti-cancer interferons (IFNs) can effectively kill cancer cells and extend the survival of mice with metastatic ovarian cancer, new research results show. The ... Read more
A large-scale screening provided a system to prioritize gene targets for the potential development of tailored cancer therapies. According to the scientists, the findings may also help produce the ... Read more
Women with invasive epithelial ovarian cancer have better survival rates at five years of diagnosis if they carry mutations in the BRCA1 and BRCA2 genes. However, this benefit decreases ... Read more